Upon further examination of the correlation between the mRNA expression levels of these pivotal genes and the pathological staging of NSCLC, a considerable variation in the expression levels of MMP3, MMP9, and ALOX5 was evident across different pathological stages (Fig. 7b). This evidence concerns the gene ALOX5 and non-small cell lung carcinoma.